MedTrace Logo

Clinical Effectiveness of(VistaProof)in Comparison With ICDAS-II & Histological Validation for Detecting Occlusal Caries

NCT03940170 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2021-08-19

No results posted yet for this study

Summary

a diagnostic accuracy study control trial is to be held to evaluate the Clinical performance of quantitative light fluorescence based device (Vistacam Proof) in comparison with the visual examination and histological validation in detection of initial pits and fissures caries

Conditions

  • Light Fluorescence Device

Interventions

DEVICE

vistacam proof

Light fluorescence device

OTHER

ICDASII

visual examination

PROCEDURE

fissurotomy

histological validation

Sponsors & Collaborators

  • Mohamed samy El-sayed

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-05-13
Completion
2021-08-09
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03940170 on ClinicalTrials.gov